Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Deeper insight into how tick spit suppresses cattle immunity

- A tick saliva study reveals immune responses that could lead to better protection for cattle

- This is a joint press release by Hokkaido University, Japan; Universidade Federal do Rio Grande do Sul, Brazil; and Universidade Federal do Rio de Janeiro, Brazil


News provided by

Hokkaido University

28 Jan, 2021, 11:20 GMT

Share this article

Share toX

Share this article

Share toX

SAPPORO, Japan, Jan. 28, 2021 /PRNewswire/ -- Scientists from Hokkaido University, Japan and Universidade Federal do Rio Grande do Sul and Universidade Federal do Rio de Janeiro, Brazil, have revealed that substances in tick saliva activates immune response-suppressing proteins in cattle that facilitates the transmission of tick-borne diseases. The finding was published in the journal Scientific Reports and could help in the development of alternative control strategies.

Continue Reading
This image opens in the lightbox
The Asian blue tick with its eggs (Photo: Itabajara da Silva Vaz Jr)

The Asian blue tick, Rhipicephalus microplus, feeds on cattle, causing skin lesions, chronic blood loss and transmission of disease-causing parasites. The costs of preventing and treating disease and loss of some cattle are considerable in many parts of the world.

Some ticks have developed resistance against currently used acaricides, the tick equivalent of insecticides. To develop alternative strategies that can better protect cattle, such as vaccines, scientists need to better understand tick infections at the molecular level. For example, scientists already know that tick saliva suppresses the immune response in cattle, facilitating the transmission of tick-borne parasites, but the exact process has not been fully clarified.

Infectious disease veterinarian, Satoru Konnai, and scientists at Hokkaido University in Japan and colleagues in Brazil investigated what happens to immune cells when they are exposed to tick saliva. The team found that substances in tick saliva, likely a lipid compound called a prostaglandin, increase the expression of two specific cellular membrane proteins on some immune cells. The interaction of these proteins, called programmed cell death protein 1 (PD-1) and programmed death-ligand 1 (PD-L1), leads to the suppression of an immune cell called helper T cell (Th1). This means that the cattle's immune response is less able to combat invading tick-borne parasites.

Further investigation showed Asian blue tick saliva contains a high concentration of prostaglandin E2, which is known to induce PD-L1 expression. However future studies need to confirm if prostaglandin E2 plays a direct role in suppressing the cattle immune response. Also, since this study involved cells in the laboratory, the team says further research in live cattle is needed.

"Our findings suggest that Asian blue tick saliva inhibits the immune responses of helper T cells, at least in part, via the interaction between PD-1 and PD-L1," says Konnai.

Associate Professor Satoru Konnai of the Laboratory of Infectious Diseases at Hokkaido University conducts research on the development of novel therapeutic strategy for intractable diseases control in animals; the pathogenesis of bovine leukemia; analysis of mechanism of tick-borne pathogen transmission and development of anti-tick vaccines.

Contacts:

Associate Professor Satoru Konnai
Laboratory of Infectious Diseases
Faculty of Veterinary Medicine
Hokkaido University
Tel: +81-11-706-5216
Email: konnai[at]vetmed.hokudai.ac.jp

Professor Itabajara da Silva Vaz Jr
Department of Veterinary Clinical Pathology
Universidade Federal do Rio Grande do Sul
Tel: +55-51-3308-6078
Email: itabajara.vaz[at]ufrgs.br

Professor Carlos Logullo
Leopoldo De Meis Institute of Medical Biochemistry
Universidade Federal do Rio de Janeiro
Tel: +55-21-3938-6786
Email: carloslogullo[at]yahoo.com.br

Sohail Keegan Pinto (International Public Relations Specialist)
Public Relations Division
Hokkaido University
Tel: +81-11-706-2185
Skype: hokudai.pr1
Email: en-press[at]general.hokudai.ac.jp

Assessoria de Imprensa
Universidade Federal do Rio Grande do Sul (UFRGS)
Tel: +55-51-3308-4008
Email: imprensa[at]ufrgs.br

Assessoria de Imprensa
Reitoria - Coordenadoria de Comunicação Social
Universidade Federal do Rio de Janeiro (UFRJ)
Email: press[at]ufrj.br

Research paper:

Yamato Sajiki, et al. Tick saliva-induced programmed death-1 and PD-ligand 1 and its related host immunosuppression. Scientific Reports. January 13, 2021.

DOI: 10.1038/s41598-020-80251-y

Funding:

This research was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI (19KK0172); Japan Agency for Medical Research and Development (AMED; JP19fk0108068); the Project of the National Agriculture and Food Research Organization (NARO) – Bio-oriented Technology Research Advancement Institution (Research program on development of innovative technology, number 26058 BC; the special scheme project on regional developing strategy, grant 16817557); the JSPS and Coordination for the Improvement of Higher Education Personnel (CAPES), Brazil, under the Japan-Brazil Research Cooperative Program (88881.153222/2017-01); and the National Council for Scientific and Technological Development (CNPq), Brazil (465678/2014-9, 405763/2018-2, 141395/2016-8).

Related Press Releases:

The drug combination effective against bovine leukemia

Unraveling the immunopathogenesis of Johne's disease

New therapeutic antibody for dog cancers

Overcoming immune suppression to fight against bovine leukemia

Photo: https://mma.prnewswire.com/media/1428763/Hokkaido_University_Tick_Image.jpg

Modal title

Also from this source

Scientists discover a single-electron bond in a carbon-based compound

Scientists discover a single-electron bond in a carbon-based compound

Researchers at Hokkaido University and the University of Tokyo have discovered a stable single-electron covalent bond between two carbon atoms,...

More Releases From This Source

Explore

STEM (Science, Tech, Engineering, Math)

STEM (Science, Tech, Engineering, Math)

Education

Education

Medical Pharmaceuticals

Medical Pharmaceuticals

Health Care & Hospitals

Health Care & Hospitals

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.